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ABSTRACT
An inhibitor of the coagulat ion in cord plasma can be. extracted by
phosphotungstic acid or acetone.The way of act ion of this inhibitor
is tested by means of synthetic chromogenic substrates, thrombin
times, two-stage thrombin generation tests and thrombelastography.
This inhibitor seems to act mainly on the behaviour of f ibr in.The
possibitr- i ty cannot be excluded that.the inhibitor also has a small
effect on thrombin or thrombin generation. Some dif ferences in the
coagulat ion of adult and'newborn plasma may be explained by this
newborn inhibitor.
INTRODUCTION
lhe coagulat ion of  newborn plasma di f fers in var ious respects f rom that  of
adul t  p lasma. Throurbin t imes of  newborn plasma are prolonged as compared wi th
those  o f  adu l t  p l asma  ( l ) . The  concen t ra t i ons  o f  t he  v i t am in  K -dependen t  f ac -
tors and ant i thrombin I I I  in  newborn plasma are lower than those in adul t  p las-
ma  (2 ) .The  c l o t s  f o rmed , i n  newbo rn  p l asma  a re  l ess  con rp ress ib l e  and  more  t r ans -
pa ran t  t han  t hose  i n  adu l t  p l asma  a t  h i gh  i on i c  s t r eng th  ( 3 ) . r n  l 975 ,Van  Doo rm
(4) concluded f rom thrombotest  d i lut ion curves and two-stage thrombin gener-
a t i on  t es t s  t ha t  co rd  p l asma  con ta i ns  a  t h romb in  i nh i b i t o r .He  sugges ted  a
hepa r i n - l i ke  ac t i on  f o r  l h t l s  i nh i b i t o r . l i o v reve r , o the r  i nves t i ga to r s  we re  no t
ab le  t o  de te rm ine  hepa r i n .  o r  hepa r i no ids  i n  co rd  p l asma  (5 r6 ) .Mo reove r ,  t he
ques t i on  whe the r  t he re  i s  a  f e t a l  f i b r i nogen  has  no t  ye t  been  answered  (7 ) .
P rope r t i es  a t t r i bu ted  t o  f e t a l  f i b r i nogen  rn i gh t  i n  f ac t  be  Da r t l y  due  t o  t he
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presence of inhibitors.
In the present art icle we describe the attempts that l7ere made to characterize
the nay of action of the inhibitor in cord plasma'
MATERIALS AND METI1ODS
Materiqlg
A11 plasmas used were prepared as described by Muller et al.(2).ThrornboplaStin
nas prepared from human brain according to the method of Owren and Aas 
(8) '
Thrombotest reagent was purehased from Nyegaard, 0sto, thrombin as Toposta-
"ir .  
R from Roche, Basel, heparin (sodiun salt  from porcine intest inal nucosa)
and crystal l ized trypsin fron Sigma, St 'Louis'The chronogenic substrate
Chromozym 
R TH r", a gi,ft from Boehringer, Mannheim.All other chemicals were
reagent grade.
Methods
l. Preparation of plasma fract ions containing the inhibitor
Methanol/acetone precipitat ion and subsequent trypsin digestion were carr ied 
out
as described by Engelberg et a1.(9).Throinbin t imes were measured after each 
pre-
paration step (acetonermethanolrrnethanol/ 'acetone'methanoL/aCetone fol lowed by
trypsin digestion).Precipitat ion with phosphotungstic acid was effected by 
adding
one volume of water and one volume of phosphotungstic acid 
(10% Na2W02 w/v in0'67
N sulfuric acid) to two volumes of plasma.The supernatant was dialyzed against
r^7ater at 4oC and freeze-dried. '
2. Determination of inhibitor act ivi ty
The inhibitor act ivi ty l47as determined by the prolongation brought about in throm-
bin t imes,in Ehe clott ing t iures measured in a two-stage prothrombin assay, and
in the parameters of the thrombelastogram.Thrombin t imes were measured by adding
0.05  rn l  o f  a  th rombin  so lu t i -on  (10  u / rn l )  to  a  mix tu re  o f  0 .1  ml  p lasma and 0 .1
ml buffer or inhibitor preparationrunless stated other!,7ise.Two-stage Prothrombin
assays  were  per fo rmed as  descr ibed by  Hemker  e t  a l . {10) .However ,A1(0H) ,  adsorbed
human adult Or cord plasma was used instead cf batium sulfate adsorbed boyine
plasma.The A1(OH)3 adsorption was carr ied out t l t ice with a f inal plasma concen-
trat ion anounting to 12.
A11 solut ions \rere prepared in. Michaelj .s br:f fer.A11 tests were performed 
at 37oC'
The effect of heparin or the inhibitor on thrombin,generated in irunan 
plasma by
human factor X. was measured using Chroarory* 
R TH as outl ined earl ier ( i l ) '
c lot formatioo*r." observed by thrornbelastography using 
a thrornberastograph
D f rom He l l ige ,Germany. Ins tead o f  0 '3  ml  p lasma on ly  
0 '28  m1 was used and 0 '02
mL buffer (one volume l4ichaelis buffer and nine volumes 
0'92 NaCl) ' inhibitor
l i *
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solut ion and/or  protamin sul fate was added.The solubi l i ty  of  the formed c lot
i n  ace t i c  ac i d  was  t es ted  as  desc r i bed  by  Ducke r t  e t  a l . ( 12 ) .
RESULTS
A. Part ia- l  fract ionation
Table I shows the thrombin times of mixtures of normal adult Dlasma and va-
r ious plasma fract ions or buffer.
TABLE I
The effects of various plasma fract ions or buffer on the thronbin t irnes of
For the reaction 0.2 ml normal- adult pl-asrna (f ibr inogen content 3.7 g/ l)  was
incubated for 60 s with 0.1 nl plasma fract ion or buffer.Clot formation was
init iated by adding 0.5 n1 thrombin (10 U/ml).Means of 6 deterroinations.
A prol-onged thronbin time was observed when the supernatant, obtained after
precipitat ion with acetornor phosphotungstic acid, was added to normal adult
plasma. Ilorrrever, the supernatants, obbained after precipitation with metha-
no1 or methanol/acetone(with.or without subsequent tryPsio digestion)'  had
no'effect on the thrombin t imes. A11 precipitates \"tere without inhibitory
activi ty. For the fol lowing experinents use l tas made of the freeze-
dried supernatant obtained after phosphotungstic acid precipitat ion and
dialysis against water of a pool of 80 cord plasma semples of nornal newborns.
A prel iminary characterization of the freeze-dried powder from I ml plasma
gave the fol lowing eomponents: 0.3 ng protein (Lowry nethod), 0.06 ng total
saccharides (calculated from total hexose) and less than 52 phosphcl ipids
(ca lcu la ted  as  l ip id  phosphorus) .
Mode of  act ion of  the inhib i tor
Ef fect  on thronbin t imes
Fig. I  shows thronbin t imes of normal adult plasma as a function of inhibitor
preparation added, as compared to the effect of adding heparin solut ion,
B .
I
normal adult plasma
Precipitat ion
wirh
Addition of supernatant from
adult plasma newborn plasma buffer time
tine (sec) t irne (sbc) t ine (sec)
methanol
. acetone
methanol/ acetone
phosphotungstic acicl
t 3 . 4  1 4 .  l  i l . 4
1 5 . 8  5 8 . 6  l t . 4
I t . z  1 l . l  l t . l
1 2 . 4  6 0 . 0  t 2 . 4
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I nhlbitor
F I G .  I ;
Thronbin tines of mixtures of 0. I ml- normal adult plasma and 0' I rnl of
inhibitor (r -  o) or heparin solut ion (   
-  A ).  (both in Michaelis
buffer).  After one ninute incubation at 37oc 0.05 nl thronbin 
(10 u/nl)
,as aai.a. gne arbitrary unit was defined as the concentration of
inhibitor preparation oi heparin which prolonged the thrombin time to
40 seconds.
In.the same range of clott ing t imes the effect of heparin dif fered from that
of inhibitor.The resulrs sumsrized in table II  were obtained vith a l /5 di lu-
t ion of A1(OIf)3 adsorbed adul-t  or newborn normal plasma,as a f ibr inogen souree.
Clot fornation was started with various throurbin concentrat ions.The dif ference
in the ef,fect of the inhibitor on newborn and on adult material was also found
using whoLe plasma or puri f ied f ibr inogensinstead of A1(OH), adsorbed plasma
(not shown here). The dif ference r{as more pronounced in the adsorbed plasma.
2. Effect on the amidoLytic act ivi ty of thrombin
If the inhibitor possessed heparin-l ike activi ty in preparations containing
anti thrombin II I , there should be an inhibitory effect on the anidol-yt ic act ivi-
ty of thrombin and factor X. by accelerat ion of the anti thrombin II I  mediated
thrombin and fact.or x" inactivation.Therefore, the amidolyt ic act ivi ty was
measured using synthetic chromogenic substrates.ln exoeriments r^r i th puri f ied
o
o
. t o
3
o
o
o
5
0
G
o
|lL
07 1.O 1.3
[arbitnrv units.l
t!
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'sources,no effect was found on the anidolysis of S 2222 (substrate specif ic
for factor X.) or S 2238 (substrate specif ic for thrornbin).The inhibit ion of
the anidolyt ia act ivi ty of thronbin by anti thrombin II I  was not accel-erated
by the inhibitor when the reaction was carr ied out in human whol-e plasma with
human factor X" as prothrombin activator.
TABLE II
Thronbin t imes of A1(0H)r-adsorbed plasma (seconds).
Thrombin
(u/n1)
A1(OIt) yadsorbed adult plasma
+ buffer +inhibitor
A1(OH)r-adsorbed newborn plasma
+ buffer +inhibitor
5
25
1 8 . 4  3 3 .  9
1 2 .  8  2 4  . 1
8 . 2  2 l . o
3 7 , 1  >  3 0 0
r 7  . 9  t 2 4 , 7
1 2 . 8  5 4 . 3
For the reaction 0.18 rn1 A1(0H)r-adsorbed adult- or newborn plasma was incubated
for  60  s  v i th  0 .02  ml  inh ib i to r ' so lu t ion  (0 .125 ng / rn l )  o r  bu f fe r .C lo t  fo rmat ion
was init iated by aitding 0.05 ml thrombin soLution.Means of 6 deterninations.
Eig. 2 demonstrates that in the presence of normal plasma the anidolyt ic act i-
vi ty of thrombin slowly decreases an effect for which anti thrombin II I  can be
held responsible.This decay was not affected by the inhibitor using Sbout three
times the amount (1.2 mg/ml) found in a newtorn pool.Addit ion of 0.5 units
heparin/m1 caused a rapid accelerat ion of the anti thrombin II I  act ion.
3 .  E f fec t  on  th rombin  genera t ion
In the t\ro-stage method the measured clott ing t imes depend on the thrombin
concentrat ion generated in Ehe f irst incubation rnixture and on the f ibr inogen
source used in the second one.The thrornbin concentrat ion is the result of
the thronbin generat.ing enzyme system and the thrombin inactivatiorl actions
(in whole plasma mostly due to anti thrombin II I) .  Figs. 3 and 4 give the re-
sults of such two-stage methods.For the results shovrn in these f iguresrthrom-
b in  was genera ted  in  adu l t  p lasma ( f ig .3 )  o r  newborn  p lasma ( f ig .  ) ,and the
effect of the incubation mixture was determir ied using A1(bU)r-aasorbed cord
or  adu l t  p1-asna.To each incubat ion  mix tu re  0 .1  ml  o f  inh ib i to r  so lu t ion  (0 .4
mg crude preparation /ml of Miehaelis buffer) was added.
When normal adult plasma was added to the incubation mixture and the assay
was performed in either AI(OH)a adsorbed newborn or adult plasrna, the plots
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The amidolyt ic acit ivi ty of thrornbin as a function of i ts inhibit ion by an-
t i thronbin II I .  For the reaction 2 Ul normal adutt plasna' 2 Ul
phospholipids, 40 ul 0. l  M CaCl"r 2 ul human factor X" preparation and
fOO uf imidazol buffer were incfbated for two minutes. To the incubation
mix tu re  2  u l  bu f fe r  (o  -  o ) ,  inh ib i to r  so lu t ion  ( r  -  o )  (1 .2  mg/n l )  o r
heparin solut ion (* - t)  (0.5 units/ml) was added, After various second
intubation t irnes 50 Ul substrate was added and the release of p-nitro-
ani l ide \ras measured at 39 I nm. The thrombin concentrat ion was calcul-
ated from a standard curve.
of the thrombin concentrat ion versus the incubation t ime vtere the saroe. Addi-
Eion of inhibitor to the thrombin generating mixture led to a decrease of Ehe
maximum thrombin concentrat ion and to a more rapid decrease of Ehrombin con-
centrat ion with increasing incubation t ime. There was no dif ference using
A1(OH)3 adsorbed newborn or A1(OH)r-adsorbed adult plasma for the second in-
cubation, i f  thrornbin was calculated from the according standard curves. How-
ever, when newborn plasma was added to the incubation mixture, addit ion of inhi-
bitor preparation led to dif ferent curves tested on adult and newborn A1(0H)3
adsorbed plasma (f ig. a). Maximum thrombin concentrat ions vere observed at an
incubaEion t ime df 2.5 rnin, Further increase of incubation t ime was accompanied
by a more rapid decrease in thrombin concentrat ion wiren the assay r^/as performed
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or is oresent in the newborn pool.Similar results
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were obtained using Purif ied
the  second s tage. In  o rder  to
inh ib i to r  be longed to  an t i -
Incubat lon  t ime [ t t " ]
F I G . 3 .
Thrombin concentrat ion as a function of the incubation t ine in a two-
stage assay. Clot formation in A1(OH)" adsorbed newborn plasma was used
as an indirect measure of the actual dmounE of t*rrombin' generated 1n
nhole or in euglobul in fract ion plasma from adults with or without
added inhibitoi.  fne thrombin generating mixture consisted of 1.7 nl
Michae l is  bu f fe r ,  O. t  n f  p lasmi ,  0 .1  n l  inh ib i to r  so lu t ion  (0 .4  mg/ml )
or buf fer and 0.'t nt ttrrorntoplastin. Thrornbin generation ltas started rtith
I  mt  1 /30  U Cac l " .A i te r  var ious  incubat ion  t imes,o . l  m1 o f  the  incub-
.t ior, * i*t . tu r i t  added to 0.1 rul A1(OII)I  adsorbed plasma di luted 1ls,and
the clotting time was fecordecl. The thfoibin concentration was calculat-
ed from a standard curve.
: .  _ . '  rghole plasna; o ]_ ol whole plasma 
\"t i th added.inhibitor;
A_A euglobulin fract ion; o _tr;  euglobul in fract ion with added
inhibitor.
in newborn A1(0H).-adsorbed plasna compared to the assay performed in adult-  ' J
A1(0H)r-adsorbed plasma.The standard curves were the same.as for t tre assays
with alult  plasrna in the thrombin generation mixtures.Maximum thrombt" "o"":1:
trat ion was less in newborn plasma because normal newborn nlasma ot"-to:". t . : : t
of the prot 'hrombin concentrat ion found in adult plasma and because the inhibit-
f ibr inogen instead
find out to which
of  A1(OH) ,  adsorbed p lasma in
extent the effect of the added
thrombin I I I  act ion, the euglobul in f ract ions of  e i ther adul t  or  newborn plasma
were used for  the thrornbin generat ing mixture instead of  whole plasna.As showrt
396 CLOT FORMATION IN CORD PLASMA V o l . 1 1  , N o .  J / 4
Incubation tlme [min]
F I G . 4 .
Thronbin concentration as a ffiEEo.t of the incubation tine in a
two-stage assay. The procedure was as described in the legend to
fig. 3. In the thronbin generating mixture instead of adult plasma
or adult eugl-obulin fraction newborn plasma or newborn euglobulin
fract ion wiih and without added inhibitor were used. The clott ing
activity of the thrornbin generating mixture lfas measured in newborn
AI(OH)" adsorbed plasma and in the case of newborn whole plasma vith
addit idnal inhibitor also in adult A1(0H)" adsorbed plasma'
. -  ci  whole plasma; o - o, whole plasmd with inhibitor assayed in
adult i I(ot l) ,- idsorbed plasma; : t  -  t ,  vhole plasma vith inhibitor
"ss"y"a 
io nSrbotn Al(Oir)"-adsorbed plasma; a -A, euglobul in fract ion,
euglobul in fract iots with inhibitor '
in fig.3 for adult and in fig.4 for newborn euglobulin fractions in the throinbin
generating mixturesran increase in the incubation tirne gave rise to an increase
in thrombin concentrati.ons,that was diminuated by the addition of inhibitor
to the incubation mixture.Inactivation of thrombin was not observed neiEher in
eugLobuLin fract ions without addit ional inhibitor nor in fract ions with addit-
ional inhibitor.Euglobulin fractions of newborn plasma showed no measurable
thronbin after addit ion of inhibitor.The inhibit ion does not vanish io euglobul-
in fractions,so antithrombin 3 is not necessary.The maximum thronbin concen-
trat ions were less in assays with euglobul in fract ions than those in assays
with whole pLasma because of a loss of prothrornbin during fract ionation.
4. Effect on the clot quati ty
Usually clots formed by addit ion of CaCl, and thrombin do not dissolve in. '22
acetic acid within l5 nin because of the actioo of factor XIII .This behaviour
trb
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was not changed by the inhibitor. Clots formed in newborn and adult Plasma
both with and without added inhibitor remained insol-uble in 27" acetic acid
during 15 nin.In order to observe the growing of the clot and the effect on
it  by added inhibitor use was made of thrombelastography. Fig. 5 shows series
of thnombelastograms of newborn and adult plasma with various concentrat ions
of added inhibitor. Platelet-poor plasma with trasylol was used.
Inh ib i to r  p repara t ion
1.O
['nsr-l
('
c
r{
z
m
€
@
o
t
z
F I G . 5 .
Throuibelastogr:uns of newborn and adult plasma with various concen-
trat ions of added inhibitor. The mixture used consisted of 0.28 nl plas-
ma,  0 .02  ml  bu f fe r  o r  inh ib i to r  so lu t ion  and 0 .06  ml  o f  a  1 .297"  CaCI ,
solut ion. The inhibitor solut ion was prepared in buffered sal ine (on6
volume Michaelis buffer and nine volumes 0.92 NaCl).
Therefore, the measurements were not affected by thronbocytes or f ibr inolyt ic
activi t ies. The effect of the inhibitor added to newborn pLr.asma dif fered frou
the effect observed w\en inhibi:or was added to adult plasma. The effect of
inhibitor on the arnpl i tude measured was less in adult p. l-asma than in newborn
plasma. Large dif ferences were observed for the maxi.num ampli tudes, which at
the same time depended on the inhibitor concentration. The maximum anplitudes
d id  no t  change over  a  per iod  o f  18  hours .  E ig .  6  shows t l :e  ampl i tude
rneasured one i rour  a f te r  c lo t  fonnat ion  s ta r ted  (a , r r ) ,  as  func t ion  o f
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Inhibitot pr€paration
3
E
c o
o
o
F
,1
F I G . 6 .
Relation between inhibitor concentration and arnplitudes reached one
hour after the start of clot formation' '  17 ' ' -  adult 
plasma;
a-ar  newborn  p lasma.  For  de ta i l s ,  see  f ig '  5 '
inhibitor concentrat ion. The results clearly demonstrate that at low 
concen-
trat ion of inhibitor new-born plasma was more affected 
rthan adult plasna. Fig'  7
shows that an increase in the inhibitor concentrat ion gave an increase 
in the
r and k.^-t irne. I t  should be mentioned that an increase in inhibitor concen-
I U
trat ion produced an increase in both r* and krO-t ime.Considering inhibitor
concent.rat ions similar to those in the clott ing assays ( less than 2 ng/n1 
in
the present system). i t  is clear that there was only a small  dif ference betueen
adult and newborn plasma for the r- and kro-t imes. 0n the other handr the
effect of the inhibitor concentrat ion on r- and k,o-t imes was more pronounced
in adult plasma than in.newborn plasma. The r- and k,O-t imes were prolonged
by the addit ion of protamin-sulfate, both for newborn and adult plasma. The
a., value was virEually not affected by the addit ion of protamin-su1fate.t n
gaJit ion of both protamin-sulfate and inhibitor to newborn plasma produced
a lower k,^-t ine rhan addit ion of inhibitor alone (conpare table II I) .  R-t ine
I U
and a. ,  hardly changed. This indicates that  the expected increase of  the 
r- t ime
I N
by protamin-sulfate did not occur.
f.gl'r]
{l|n
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TABLE III
I
I
I
I
I
t
Thrombelastography of newborn plasma with addit ion of protamin-suLfate.
Means of 4 deternrinations.
F I G . 7 .
Thrombelastography of adult and newborn plasma' Relat ion between
inhib. i tor concentrat ion and the sum of the t imes, in which the clot
formation after addit ion of Cacl, started (r-t ime) and the t ime in
which the ampli tude reached l0 f f i  after the start of clot formation
( t , ^ - t i m e ) .  F o r  d e t a i l s ,  s e e  f i g '  5 .  o  -  o ,  a d u l t  p l a s m a ;  A -   '
I U
nelvborn DIasma.
D ISCUSSION
Van Doorm and Mul le r  e t  a l .  (2 ,4 )  found an  inh ib i to r  o f  the  coagu la t ion  in
Addit ion of 0.02 m1 protamin-
sulfate (mg/nl)
0 . 0  0 . 2 5 0 . 5
Addit ion of 0.01 ml- protamin-
su l fa te  (0 .5  ng /n l )  and 0 .01  n l  in -
h ib i to r  (0 .0  o r  5 .0  ng /n l )
inh. 5.0 ng/n1 inh. 0.0 mg/ml
r (nin)
c,o (n in)
r,n (un)
' 4 . 0 0  6 . 0 0  8 . 2 5
I  . 0 0  I  .  3 0  2 . 1 0
29  28  28
I  6 . 0 0  1 6 . 2 5
1 0 . 5 0  1 2 . 5 0
t 4  1 3
+
r
o
2
3
o
E
a
U
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o
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a b o v t 2 | 3 o f a l l s p o n t a n e o u s l y b o r n n o r m a l n e w b o r n s . I n t w o - s t a g e p r o t b r o m b i n
a s s a y s a n t i t h r o a b i n l l l i n c r e a s e d t h i s i n h i b i t i o n a n d p r o t a n i n - s u l f a t e d e c r e a s .
e d i t . T h i s . c o q l d n o t b e e x p l a i n e d b y d i f f e r e n c e , s i n t h e c o n c e n t r a t i o n s o f k n o , v m
p h y s i o l o g i c a l c o a g u l a t i o n i n h i b i t o r s . T h e s e f i n d i n g s l e d t h e m t o s u g g e s t t h a l a
heparin-1ike inhibitor was present in cord 
pLasma'
rn normal newbornswe found inhibitoryIn a poo1. of plasma of spontaneously bo:
activi ty in the supernatants obtained after 
precipitat ion with phosphotungstic
acid or acetone. From the results discussed 
be1-ow' we conclude that the princi-
p a l m o d e o f a c t i o n o f t h e p u r i f i e d i n h i b i t o r i s n o t h e p a r i n l i k e , b e c a u s e a n t i -
t h r o m b i n l l l i s n o t a p r e r e q u i s i t e f o r t h e a c t i o n o f t h e i n h i b i t o r . A l s o a n t i -
t h r o m b i n l l l r n e d i . a t e d i n a c t i v a t i o n o f t h r o m b i n i s n o t a c c e l e r a t e d b y t h e i n -
h i b i t o r i n a s y s t e m w h e r e t h r o n b i n i s a s s e s s e d b y m e a n s o f c h r o m o g e n i c s u b -
S t r a t e ( f . i e . 2 ) . T h i s d o e s n o t e x c l u d e t h a t t h e i n h i b i t o r a f f e c t s t h r o m b i n i n
a w a y d i f f e r e n t f r o m h e p a r i n , b e c a u s e t h e a m i d o l y t i c a c t i v i t y o f t h r o m b i r i n e e d s
not  be  ident ica l  to  i t s  ac t i v i t y  on  f ib r inogen 
(13) '
Further in thrombin generation tests the 
inhibitor shows an effect that per-
sisted whea anti thrombin rrr is rbmoved by 
euglobul in fract ionation (f igs' 3
a n d 4 ) a n d p r o t a m i n s u l f a t e d o e s n o t a f f e c t t h e m a i n a c t i o n o f t h e i n h i b i t o r
in thrombelastograms' i 'e '  decrease of arn with 
increase of the inhibitor
( t a b l e I I l ) . F i n a l l y , t h e w d y i n w h i c h t h e i n h i b i t o r a f f e c t e d t h r o m b i n t i m e s
was quant i ta t i ve ly  d i f fe ren t  f rom tha t  o f  hepar in  
( f i ' g '  l ) '
T h e r e i s a d i f f e r e n c e i n a c t i o n o f t h e i n h i b i t o r o n n e w b o r n p l a s m a a n d o n
adult plasma. The clott ing t irne with 
(bovine) throurbin of A1(OH)r-adsorbed
newborn pla.sma is longer than that with A1(OH)a 
adsorbed adult plasma (table
I I I ) . I n p r o t h r o m b i n t w o - s t a g e a s s a y s t h e a d d i t i o n o f i n h i b i t o r c a n r s e s l e s s
t h r o m b i n t o a r i s e . T h i s e f f e c t i s m o s t p r o n o u n c e d w i t h n e w b o r n p l a s m : o r i t s
e u g l o b u l i n f r a c t i o n i n t h e f i r s t s t a g e a n d n e w b o r n f i b r i n o g e n i n t h e s e c o n d
s t a g e ( f i g . 4 ) . T h e d i f f e i e n c e s b e t l ' e e n t h e r a h o l e p l a s m a a n d e u g l o b u l i n
c u r v e s a r e e x p l a i n e d b y t h e f a c t t h a t w h o l e p l a s m a c o n t a i n s a b o u t t y i c e t h e
a m o u n t o f p r o t h r o m b i n a s w e l l a s a n t i t h r o r n b i n l l l . T h e e f f e c t o f t h e i n h i b i t -
o r o n t h e e x p e r i m e n E w i t h r . r h o l e p l a s r n a c a n b e a t t r i b u t e d t o u n d e r e s t i m a t i o n
o f t h e a m o u n t o f t h r o m b i n g e n e r a t e d b e c a u s e o f t h e a c t i o n o f t h e i n h i b i t o r
on f ibr in formation. Yet when comparing the 
effect on whole plasna and
e u g l o b u l i n i t i s c l e a r t h a t t h e r e m u s t b e a n o t h e r i n h i b i t o r a e t i o n p r e s e n t
t o o ' b e c a u s . e i n t h e e u g l o b u l i n e x p e r i m e n t t h e i n h i b i t i o n o b s e r v e d i s m u c h
m o r e p r o n o u n 6 e d . T h e s a m e h o t d s f o r t h e e x p e r i m e n t s h o w n i n f i g . 4 . T h i s
effect in throrubin generation remains to be infrest igated',  
i t  is much less
pronounced than the effect on f ibr in forrnation'
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The conclusion that the inhibitor act.s on f ibr in formation is supported by
the results of thrombelastography. The inhibitor affects both r- and k,O-
t ime as well  as .the anpli tudes. Addit ion of reasonable amounts of inhibitor
causes only a sma11 increase in the r- and kr '- t ine. The same amount of in-
hibitor produces a decrease inthe anpli tudes. This decrease is much more
pronounced in newborn than in adult plasma. Increase in r- and k16-t ine
reflects the presence of heparin or f ibr in degradation products or a de-
creased level of some coagulat ion factor act ivi ty. The ampl- i tudes in thromb-
elastograms represent the clot qual i ty mostly determined by frbrin, thrombo-
cy tes  and f ib r ino ly t i c  subs tances  (15) .  Thrombocyres  and f ib r ino ly t i c  ac-
t ivi t ies -rere not present in our samples.
Lrhether the clot qual i ty is changed by the formation of antrabnormal"
f ibr in or by an "abnormal" f ibr in aggregation cannot be ascertained. Dif-
ferences between f ibr in aggregation of nerrrborn piasma and that of adult
plasma were found by Galanakis and by Krause and Maus (3, 6).
The cross-l inking of f ibr in polynrers is not inf luenced by the inhibitor,
as clots made in presence and absence of the inhibitor are equally unsoluble
in urea and acetic acid.
Our assumpEion that the newborn inhibitor premari ly acts on f ibr in includes
tha t  there  is  a  fe ta l  f ib r inogen or  f ib r in  because o f  the  d i f fe rences
between the action of the inhibitor on newborn and adult material.  The
f ind ing  o f  Teger -N i lsson and Eke lund (16)  tha t  the  c lo r rab i l i t y  o f  pur i f ied
fibrinogen from newborn plasrna does not dif fer from that of adult plasma
does no t  con t rad ic t  th is  assumpt ion .  The c lo t tab i l i t y  o f  fe ta l  f ib r inogen
could be affected only in the presence of the inhibitor and would there-
fo re  no t  be  observed in  pur i f ied  mater ia l .
Prolongation of average thrombin t ime and dif ferences in the clot qual i ty
in newborn plasma compared \r i th those in adult plasma could be explained
by the action of the inhibitor and the presence of a fetaL f ibr inogen.
Apart from that the concentrat ions of the normar procoagurant and anti-
coagulant factors are not the same in the adult and in the newborn (2),there
is also a smalI as yet unexplained inhibit ing effect on thrombin generation.
The mode of act ion of the inhibitor found is more interestingsince we could
show that the level of inhibitor in cord plasma has a posit ive relat ion to
the maturi ty of the newborn (birth weight, duration of pregnancy) and the
way of del ivery with a maxinum after vaginal operation and a minimum after
caesarean sec t ion  (17) .  rnves t iga t ions  to  charac ter ize  the  mode o f  ac t ion
4or
4oz
of the inhibitor using purif ied newborn
means of gel- and imlunoelectrophoresis
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and adult fibrinogen and thrornbin by
are at lrork.
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